Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2288 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

BioXell’s overactive bladder trial fails endpoint

BioXell, an Italy-based biopharmaceutical company, has reported top-line results of its Phase IIb trial of Elocalcitol in patients suffering from overactive bladder. The overactive bladder (OAB) trial was

NeoStem raises $11 million in financing

The investing firms are RimAsia Capital Partners, a pan-Asia private equity firm investing $5 million; Enhance Biomedical Holding based in Shanghai, also investing $5 million and Elancrest Investments,